Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
Latest Podcasts
CFP Podcast: Perennial post-examination surprises
As a family medicine teacher or Program Director, have you ever had a highly capable resident learner fail the Simulated Office Oral (SOO) portion of the CCFP examination? Have you…
BS Medicine Episode #586: It’s time to challenge penicillin allergy labels
In episode 586, Mike and James invite Émélie Braschi back to the podcast to talk about the tricky issue of how to deal with a potential penicillin allergy. Believe it…
BS Medicine Episode #585: PREMIUM – Beta-blockers after an MI and respiratory specialists for COPD
In episode 585, Mike and James finally get back to being PREMIUM. We review the REDUCE-AMI trial which tried to answer the question – do you need to use a…
September 19, 2024
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
Please provide any additional comments (optional).